David Edward Clark

Title: David Edward Clark - Innovator in Pharmaceutical Research

Introduction: David Edward Clark is an inventor based in Parma, Italy. He is currently associated with Chiesi Farmaceutici S.p.a., where he contributes to the field of pharmaceutical research. Although he has not yet been granted any patents, his work focuses on developing innovative compounds for therapeutic use.

Latest Patent Applications: David Edward Clark has been involved in several notable patent applications. One of his latest applications is for Tetrahydrothieno pyridine derivatives as DDR inhibitors. This invention relates to compounds that inhibit Discoidin Domain Receptors, along with methods of preparing these compounds, pharmaceutical compositions containing them, and their therapeutic applications. These compounds may be beneficial in treating various disorders associated with DDR mechanisms. Another significant application is for Dihydrofuropyridine derivatives as Rho-kinase inhibitors. This invention involves compounds that inhibit Rho Kinase, which are dihydrofuropyridine derivatives. The application includes methods of preparing these compounds, pharmaceutical compositions, and their therapeutic uses, particularly in treating disorders related to ROCK enzymes mechanisms, such as pulmonary diseases including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and pulmonary arterial hypertension (PAH).

Conclusion: David Edward Clark is a dedicated inventor in the pharmaceutical industry, focusing on innovative solutions for complex health issues. His latest patent applications reflect his commitment to advancing medical science and improving patient outcomes.